262 related articles for article (PubMed ID: 23807504)
1. The functions and applications of RGD in tumor therapy and tissue engineering.
Wang F; Li Y; Shen Y; Wang A; Wang S; Xie T
Int J Mol Sci; 2013 Jun; 14(7):13447-62. PubMed ID: 23807504
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review.
Alipour M; Baneshi M; Hosseinkhani S; Mahmoudi R; Jabari Arabzadeh A; Akrami M; Mehrzad J; Bardania H
J Biomed Mater Res A; 2020 Apr; 108(4):839-850. PubMed ID: 31854488
[TBL] [Abstract][Full Text] [Related]
3. A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
Park J; Singha K; Son S; Kim J; Namgung R; Yun CO; Kim WJ
Cancer Gene Ther; 2012 Nov; 19(11):741-8. PubMed ID: 23018622
[TBL] [Abstract][Full Text] [Related]
4. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature.
Gerlag DM; Borges E; Tak PP; Ellerby HM; Bredesen DE; Pasqualini R; Ruoslahti E; Firestein GS
Arthritis Res; 2001; 3(6):357-61. PubMed ID: 11714389
[TBL] [Abstract][Full Text] [Related]
5. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports.
Petrie TA; Capadona JR; Reyes CD; García AJ
Biomaterials; 2006 Nov; 27(31):5459-70. PubMed ID: 16846640
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.
Yang H; Kao WJ
Int J Nanomedicine; 2007; 2(1):89-99. PubMed ID: 17722516
[TBL] [Abstract][Full Text] [Related]
7. The neovasculature homing motif NGR: more than meets the eye.
Corti A; Curnis F; Arap W; Pasqualini R
Blood; 2008 Oct; 112(7):2628-35. PubMed ID: 18574027
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.
Shukla R; Thomas TP; Peters J; Kotlyar A; Myc A; Baker JR
Chem Commun (Camb); 2005 Dec; (46):5739-41. PubMed ID: 16307130
[TBL] [Abstract][Full Text] [Related]
9. Integrins in drug targeting-RGD templates in toxins.
Lu X; Lu D; Scully MF; Kakkar VV
Curr Pharm Des; 2006; 12(22):2749-69. PubMed ID: 16918409
[TBL] [Abstract][Full Text] [Related]
10. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.
Meyer A; Auernheimer J; Modlinger A; Kessler H
Curr Pharm Des; 2006; 12(22):2723-47. PubMed ID: 16918408
[TBL] [Abstract][Full Text] [Related]
11. Enhanced apoptosis-inducing function of MDA-7/IL-24 RGD mutant via the increased adhesion to tumor cells.
Pei DS; Yang ZX; Zhang BF; Yin XX; Li LT; Li HZ; Zheng JN
J Interferon Cytokine Res; 2012 Feb; 32(2):66-73. PubMed ID: 22248086
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
Garanger E; Boturyn D; Dumy P
Anticancer Agents Med Chem; 2007 Sep; 7(5):552-8. PubMed ID: 17896915
[TBL] [Abstract][Full Text] [Related]
13. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
[TBL] [Abstract][Full Text] [Related]
14. A self-assembling peptide matrix used to control stiffness and binding site density supports the formation of microvascular networks in three dimensions.
Stevenson MD; Piristine H; Hogrebe NJ; Nocera TM; Boehm MW; Reen RK; Koelling KW; Agarwal G; Sarang-Sieminski AL; Gooch KJ
Acta Biomater; 2013 Aug; 9(8):7651-61. PubMed ID: 23603000
[TBL] [Abstract][Full Text] [Related]
15. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles.
Danhier F; Pourcelle V; Marchand-Brynaert J; Jérôme C; Feron O; Préat V
Methods Enzymol; 2012; 508():157-75. PubMed ID: 22449925
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of arginine-glycine-aspartic acid peptides in acute renal injury.
Goligorsky MS; Noiri E; Kessler H; Romanov V
Clin Exp Pharmacol Physiol; 1998; 25(3-4):276-9. PubMed ID: 9590583
[TBL] [Abstract][Full Text] [Related]
17. RGD-dependent integrins are mechanotransducers in dynamically compressed tissue-engineered cartilage constructs.
Kock LM; Schulz RM; van Donkelaar CC; Thümmler CB; Bader A; Ito K
J Biomech; 2009 Sep; 42(13):2177-82. PubMed ID: 19656515
[TBL] [Abstract][Full Text] [Related]
18. Engineering of Bio-Adhesive Ligand Containing Recombinant RGD and PHSRN Fibronectin Cell-Binding Domains in Fusion with a Colored Multi Affinity Tag: Simple Approach for Fragment Study from Expression to Adsorption.
Ben Abla A; Boeuf G; Elmarjou A; Dridi C; Poirier F; Changotade S; Lutomski D; Elm'selmi A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298982
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelled RGD peptides for imaging and therapy.
Gaertner FC; Kessler H; Wester HJ; Schwaiger M; Beer AJ
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S126-38. PubMed ID: 22388629
[TBL] [Abstract][Full Text] [Related]
20. Modulating angiogenesis with integrin-targeted nanomedicines.
Duro-Castano A; Gallon E; Decker C; Vicent MJ
Adv Drug Deliv Rev; 2017 Sep; 119():101-119. PubMed ID: 28502767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
